1. Home
  2. AISP vs LIXT Comparison

AISP vs LIXT Comparison

Compare AISP & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$2.90

Market Cap

99.9M

Sector

Finance

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$7.39

Market Cap

107.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AISP
LIXT
Founded
2006
2005
Country
United States
United States
Employees
65
3
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.9M
107.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AISP
LIXT
Price
$2.90
$7.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
731.8K
332.0K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$222.88
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
$3.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$0.68
52 Week High
$7.20
$7.78

Technical Indicators

Market Signals
Indicator
AISP
LIXT
Relative Strength Index (RSI) 54.88 65.67
Support Level $2.71 $2.90
Resistance Level $3.32 N/A
Average True Range (ATR) 0.27 0.85
MACD -0.02 -0.04
Stochastic Oscillator 45.75 91.41

Price Performance

Historical Comparison
AISP
LIXT

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture. Airship AI's software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.

Share on Social Networks: